21-hydroxylase autoantibodies are more prevalent in Turner syndrome but without an association to the autoimmune polyendocrine syndrome type I.

Berglund, A; Cleemann, L; Oftedal, B E; Holm, K; Husebye, E S; Gravholt, C H

Berglund, A; Cleemann, L; Oftedal, B E; Holm, K; Husebye, E S; Gravholt, C H.

Afiliação

Berglund A; Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark.
Cleemann L; Department of Molecular Medicine, Aarhus University Hospital, Denmark.
Oftedal BE; Department of Pediatrics, North Sealand Hospital, Hillerød, Denmark.
Holm K; Department of Clinical Science, University of Bergen, Norway.
Husebye ES; K.G. Jebsen Center for Autoimmune Disorders, University of Bergen, Norway.
Gravholt CH; Department of Pediatrics, North Sealand Hospital, Hillerød, Denmark.

Clin Exp Immunol ; 195(3): 364-368, 2019 03.

Article em En | MEDLINE | ID: mdl-30372540

Assuntos

Autoanticorpos/sangue; Poliendocrinopatias Autoimunes/imunologia; Esteroide 21-Hidroxilase/imunologia; Síndrome de Turner/imunologia; Adolescente; Adulto; Criança; Feminino; Humanos; Pessoa de Meia-Idade; Adulto Jovem

Palavras-chave

Turner syndrome; adrenal insufficiency; autoimmune polyendocrine syndrome type

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoanticorpos / Síndrome de Turner / Esteroide 21-Hidroxilase / Poliendocrinopatias Autoimunes Tipo de estudo: Risk_factors_studies Limite: Adolescent / Adult / Child / Female / Humans / Middle aged Idioma: En Revista: Clin Exp Immunol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Dinamarca

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google